Uscom 4C Quarterly Results Q2 FY22
Uscom today released its Appendix 4C – Results for the quarter ending 31 December 2021.
News and Announcements
Our aim is to keep investors and interested parties informed of Uscom news events and announcements
24Jan
24Nov
Prof Rob Phillips Presents at the NWR Virtual Healthcare Day
Uscom’s Chairman & CEO Prof Rob Phillips presents on new Uscom developments at the NWR Virtual Healthcare Conference “Uscom New Growth”.
03Nov
Uscom and US Koneksa Extend Technology Partnership
Uscom extended its ongoing partnership with digital biomarker leader Koneksa to develop and use Uscom’s digital patient-monitoring technology for spirometers in clinical trials.
23Sep
BP+ 94% Effective for AF Screening in Primary Care
A recent study confirms the high accuracy of the Uscom BP+ central blood pressure monitor for detection of the dangerous cardiac rhythm abnormality Atrial Fibrillation (AF) in a primary care setting. This result confirms that BP+ suprasystolic oscillometry is 94% effective for detection of AF in home care environments and may be used as a screening investigation.